Fast neutron radiotherapy: for equal or for better?

Area of Science:

• Radiation oncology
• Radiobiology
• Medical physics

Background:

• Fast neutron radiotherapy utilizes high Linear Energy Transfer (LET) radiation, exhibiting distinct biological effects compared to X-rays.
• Key radiobiological differences include variations in the oxygen enhancement ratio, cell cycle sensitivity, and sublethal damage contribution.
• Relative Biological Effectiveness (RBE) of fast neutrons varies significantly across different tumor types and normal tissues.

Purpose of the Study:

• To review the clinical applications and outcomes of fast neutron radiotherapy.
• To assess the factors influencing the therapeutic gain and effectiveness of neutron therapy.
• To identify challenges and future directions for optimizing fast neutron radiotherapy.

Main Methods:

• Analysis of clinical data from approximately 6,000 patients treated with fast neutron beams.
• Evaluation of tumor response based on differentiation and growth rate, including measurements of human pulmonary metastases.
• Review of technical and physical conditions affecting neutron radiotherapy applications.

Main Results:

• Encouraging results observed for inoperable salivary gland malignancies.
• Limited therapeutic gain reported for bladder and rectal cancers, soft tissue sarcomas, and cervical carcinomas.
• Disappointing responses noted in brain tumor treatments.
• RBE is higher for slowly growing, well-differentiated tumors compared to poorly differentiated ones.

Conclusions:

• Fast neutron radiotherapy presents a complex clinical profile with site-specific variations in efficacy.
• Inadequate physical and technical conditions have likely led to underestimation of its potential benefits in many cases.
• Well-designed clinical trials using advanced technology are crucial to definitively determine the value of fast neutron radiotherapy.